NCT06398236View on ClinicalTrials.gov

Open-labelled Study to Evaluate the Effect of SE5-OH Tablets on Healthy Women With Menopausal Symptoms

NACompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

March 17, 2023

Primary Completion Date

July 18, 2024

Study Completion Date

October 16, 2024

Conditions
Menopause
Interventions
DIETARY_SUPPLEMENT

SE5-OH tablets

SE5-OH (Fermented Soy germ, include S-equol), Crystalline cellulose, Oats fiber, Agar, Cyclic oligosaccharide, HPMC, Reduced syrup.

Trial Locations (1)

Unknown

Clínica Palacios Madrid, Madrid

Sponsors

Collaborators (1)

Adknoma Health Research
All Listed Sponsors
collaborator

Adknoma Health Research

INDUSTRY

lead

Nutrition & Sante Iberia

INDUSTRY